11th Vaccines Research and Development: All Things Considered Conference

GTC is proud to present its 11th Vaccines Research and Development: All Things Considered Conference, to be held in Boston, MA on July 8-10, 2013. As the name indicates, this conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline. Development of new vaccines truly requires a consideration of many things. We examine vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry. The latest information on the new malaria, HIV, tumor, and therapeutic vaccines, DNA vaccines, RNA vaccines, adjuvants, mucosal and other delivery mechanisms will be presented, as will updates on governmental priorities, funding and partnership opportunities. Representatives from the HHS, BARDA and NIH as well as NGO will provide a first-hand perspective into current US vaccines policy, regulation and funding as well as updates on the pandemic and bio-defense policy. All aspects from discovery to marketing will be covered.